Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 74

1.

'Speaking about the unspeakable': Clinical psychologists views on the role of the profession regarding 'forced care' of older adults without capacity.

Watts SJ, Jackman L, Howarth A.

Dementia (London). 2017 Jan 1:1471301216688545. doi: 10.1177/1471301216688545. [Epub ahead of print]

PMID:
28142255
2.

The effects of implicit gender role theories on gender system justification: Fixed beliefs strengthen masculinity to preserve the status quo.

Kray LJ, Howland L, Russell AG, Jackman LM.

J Pers Soc Psychol. 2017 Jan;112(1):98-115. doi: 10.1037/pspp0000124.

PMID:
28032774
3.

Comparing initial diagnostic excision biopsy of cutaneous malignant melanoma in primary versus secondary care: A study of Irish National data.

Doherty SM, Jackman LM, Kirwan JF, Dunne D, O'Connor KG, Rouse JM.

Eur J Gen Pract. 2016 Dec;22(4):267-273. doi: 10.1080/13814788.2016.1232386. Epub 2016 Nov 16.

PMID:
27848254
4.

A Model to Predict the Risk of Keratinocyte Carcinomas.

Whiteman DC, Thompson BS, Thrift AP, Hughes MC, Muranushi C, Neale RE, Green AC, Olsen CM; QSkin Study.

J Invest Dermatol. 2016 Jun;136(6):1247-54. doi: 10.1016/j.jid.2016.02.008. Epub 2016 Feb 22.

5.

High-Throughput Amplicon-Based Copy Number Detection of 11 Genes in Formalin-Fixed Paraffin-Embedded Ovarian Tumour Samples by MLPA-Seq.

Kondrashova O, Love CJ, Lunke S, Hsu AL; Australian Ovarian Cancer Study (AOCS) Group, Waring PM, Taylor GR.

PLoS One. 2015 Nov 16;10(11):e0143006. doi: 10.1371/journal.pone.0143006. eCollection 2015.

6.

Micro-skills of group formulations in care settings: Working with expressions of staff distress.

Jackman L, Fielden A, Pearson S.

Dementia (London). 2017 May;16(4):523-536. doi: 10.1177/1471301215596495. Epub 2015 Jul 28.

PMID:
26224746
7.

Sun Protection and Skin Examination Practices in a Setting of High Ambient Solar Radiation: A Population-Based Cohort Study.

Olsen CM, Thompson BS, Green AC, Neale RE, Whiteman DC; QSkin Sun and Health Study Group.

JAMA Dermatol. 2015 Sep;151(9):982-90. doi: 10.1001/jamadermatol.2015.0739.

PMID:
26039788
8.

Whole-genome characterization of chemoresistant ovarian cancer.

Patch AM, Christie EL, Etemadmoghadam D, Garsed DW, George J, Fereday S, Nones K, Cowin P, Alsop K, Bailey PJ, Kassahn KS, Newell F, Quinn MC, Kazakoff S, Quek K, Wilhelm-Benartzi C, Curry E, Leong HS; Australian Ovarian Cancer Study Group, Hamilton A, Mileshkin L, Au-Yeung G, Kennedy C, Hung J, Chiew YE, Harnett P, Friedlander M, Quinn M, Pyman J, Cordner S, O'Brien P, Leditschke J, Young G, Strachan K, Waring P, Azar W, Mitchell C, Traficante N, Hendley J, Thorne H, Shackleton M, Miller DK, Arnau GM, Tothill RW, Holloway TP, Semple T, Harliwong I, Nourse C, Nourbakhsh E, Manning S, Idrisoglu S, Bruxner TJ, Christ AN, Poudel B, Holmes O, Anderson M, Leonard C, Lonie A, Hall N, Wood S, Taylor DF, Xu Q, Fink JL, Waddell N, Drapkin R, Stronach E, Gabra H, Brown R, Jewell A, Nagaraj SH, Markham E, Wilson PJ, Ellul J, McNally O, Doyle MA, Vedururu R, Stewart C, Lengyel E, Pearson JV, Waddell N, deFazio A, Grimmond SM, Bowtell DD.

Nature. 2015 May 28;521(7553):489-94. doi: 10.1038/nature14410. Erratum in: Nature. 2015 Nov 19;527(7578):398.

PMID:
26017449
9.

Using the Newcastle Model to understand people whose behaviour challenges in dementia care.

Jackman L, Beatty A.

Nurs Older People. 2015 Mar;27(2):32-9. doi: 10.7748/nop.27.2.32.e666.

PMID:
25727635
10.

Two important legal events that may radically shape the future delivery of dementia care in England and Wales.

Jackman L, Emmett C.

Int J Geriatr Psychiatry. 2015 Jan;30(1):105. doi: 10.1002/gps.4201. No abstract available.

PMID:
25502900
11.

Legal implications of restrictive physical interventions in people with dementia.

Jackman L, Emmett C, Sharp T, Marshall J.

Nurs Older People. 2014 Nov;26(10):24-9. doi: 10.7748/nop.26.10.24.e632.

PMID:
25430843
12.

Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk.

Painter JN, O'Mara TA, Batra J, Cheng T, Lose FA, Dennis J, Michailidou K, Tyrer JP, Ahmed S, Ferguson K, Healey CS, Kaufmann S, Hillman KM, Walpole C, Moya L, Pollock P, Jones A, Howarth K, Martin L, Gorman M, Hodgson S; National Study of Endometrial Cancer Genetics Group (NSECG); CHIBCHA Consortium, De Polanco MM, Sans M, Carracedo A, Castellvi-Bel S, Rojas-Martinez A, Santos E, Teixeira MR, Carvajal-Carmona L, Shu XO, Long J, Zheng W, Xiang YB; Australian National Endometrial Cancer Study Group (ANECS), Montgomery GW, Webb PM, Scott RJ, McEvoy M, Attia J, Holliday E, Martin NG, Nyholt DR, Henders AK, Fasching PA, Hein A, Beckmann MW, Renner SP, Dörk T, Hillemanns P, Dürst M, Runnebaum I, Lambrechts D, Coenegrachts L, Schrauwen S, Amant F, Winterhoff B, Dowdy SC, Goode EL, Teoman A, Salvesen HB, Trovik J, Njolstad TS, Werner HM, Ashton K, Proietto T, Otton G, Tzortzatos G, Mints M, Tham E; RENDOCAS, Hall P, Czene K, Liu J, Li J, Hopper JL, Southey MC; Australian Ovarian Cancer Study (AOCS), Ekici AB, Ruebner M, Johnson N, Peto J, Burwinkel B, Marme F, Brenner H, Dieffenbach AK, Meindl A, Brauch H; GENICA Network, Lindblom A, Depreeuw J, Moisse M, Chang-Claude J, Rudolph A, Couch FJ, Olson JE, Giles GG, Bruinsma F, Cunningham JM, Fridley BL, Børresen-Dale AL, Kristensen VN, Cox A, Swerdlow AJ, Orr N, Bolla MK, Wang Q, Weber RP, Chen Z, Shah M, French JD, Pharoah PD, Dunning AM, Tomlinson I, Easton DF, Edwards SL, Thompson DJ, Spurdle AB.

Hum Mol Genet. 2015 Mar 1;24(5):1478-92. doi: 10.1093/hmg/ddu552. Epub 2014 Nov 6.

13.

ABCA transporter gene expression and poor outcome in epithelial ovarian cancer.

Hedditch EL, Gao B, Russell AJ, Lu Y, Emmanuel C, Beesley J, Johnatty SE, Chen X, Harnett P, George J; Australian Ovarian Cancer Study Group, Williams RT, Flemming C, Lambrechts D, Despierre E, Lambrechts S, Vergote I, Karlan B, Lester J, Orsulic S, Walsh C, Fasching P, Beckmann MW, Ekici AB, Hein A, Matsuo K, Hosono S, Nakanishi T, Yatabe Y, Pejovic T, Bean Y, Heitz F, Harter P, du Bois A, Schwaab I, Hogdall E, Kjaer SK, Jensen A, Hogdall C, Lundvall L, Engelholm SA, Brown B, Flanagan J, Metcalf MD, Siddiqui N, Sellers T, Fridley B, Cunningham J, Schildkraut J, Iversen E, Weber RP, Berchuck A, Goode E, Bowtell DD, Chenevix-Trench G, deFazio A, Norris MD, MacGregor S, Haber M, Henderson MJ.

J Natl Cancer Inst. 2014 Jun 23;106(7). pii: dju149. doi: 10.1093/jnci/dju149. Print 2014 Jul.

14.

Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancer.

Gao B, Russell A, Beesley J, Chen XQ, Healey S, Henderson M, Wong M, Emmanuel C, Galletta L, Johnatty SE, Bowtell D; Australian Ovarian Cancer Study Group, Haber M, Norris M, Harnett P, Chenevix-Trench G, Balleine RL, deFazio A.

Sci Rep. 2014 May 9;4:4669. doi: 10.1038/srep04669.

15.

Micro-skills of group formulations in care settings.

Jackman LJ, Wood-Mitchell A, James IA.

Dementia (London). 2014 Jan;13(1):23-32. doi: 10.1177/1471301212442463. Epub 2012 May 21.

PMID:
24381037
16.

Genital powder use and risk of ovarian cancer: a pooled analysis of 8,525 cases and 9,859 controls.

Terry KL, Karageorgi S, Shvetsov YB, Merritt MA, Lurie G, Thompson PJ, Carney ME, Weber RP, Akushevich L, Lo-Ciganic WH, Cushing-Haugen K, Sieh W, Moysich K, Doherty JA, Nagle CM, Berchuck A, Pearce CL, Pike M, Ness RB, Webb PM; Australian Cancer Study (Ovarian Cancer); Australian Ovarian Cancer Study Group, Rossing MA, Schildkraut J, Risch H, Goodman MT; Ovarian Cancer Association Consortium.

Cancer Prev Res (Phila). 2013 Aug;6(8):811-21. doi: 10.1158/1940-6207.CAPR-13-0037. Epub 2013 Jun 12.

17.

Nonequivalent gene expression and copy number alterations in high-grade serous ovarian cancers with BRCA1 and BRCA2 mutations.

George J, Alsop K, Etemadmoghadam D, Hondow H, Mikeska T, Dobrovic A, deFazio A; Australian Ovarian Cancer Study Group, Smyth GK, Levine DA, Mitchell G, Bowtell DD.

Clin Cancer Res. 2013 Jul 1;19(13):3474-84. doi: 10.1158/1078-0432.CCR-13-0066. Epub 2013 Apr 30.

18.

Impact of weight change and weight cycling on risk of different subtypes of endometrial cancer.

Nagle CM, Marquart L, Bain CJ, O'Brien S, Lahmann PH, Quinn M, Oehler MK, Obermair A, Spurdle AB, Webb PM; Australian National Endometrial Cancer Study Group.

Eur J Cancer. 2013 Aug;49(12):2717-26. doi: 10.1016/j.ejca.2013.03.015. Epub 2013 Apr 11.

PMID:
23583438
19.

Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium.

Olsen CM, Nagle CM, Whiteman DC, Ness R, Pearce CL, Pike MC, Rossing MA, Terry KL, Wu AH; Australian Cancer Study (Ovarian Cancer); Australian Ovarian Cancer Study Group, Risch HA, Yu H, Doherty JA, Chang-Claude J, Hein R, Nickels S, Wang-Gohrke S, Goodman MT, Carney ME, Matsuno RK, Lurie G, Moysich K, Kjaer SK, Jensen A, Hogdall E, Goode EL, Fridley BL, Vierkant RA, Larson MC, Schildkraut J, Hoyo C, Moorman P, Weber RP, Cramer DW, Vitonis AF, Bandera EV, Olson SH, Rodriguez-Rodriguez L, King M, Brinton LA, Yang H, Garcia-Closas M, Lissowska J, Anton-Culver H, Ziogas A, Gayther SA, Ramus SJ, Menon U, Gentry-Maharaj A, Webb PM; Ovarian Cancer Association Consortium.

Endocr Relat Cancer. 2013 Mar 22;20(2):251-62. doi: 10.1530/ERC-12-0395. Print 2013 Apr.

20.

Patterns of chemotherapy treatment for women with invasive epithelial ovarian cancer--a population-based study.

Jordan S, Steer C, DeFazio A, Quinn M, Obermair A, Friedlander M, Francis J, O'Brien S, Goss G, Wyld D, Australian Ovarian Cancer Study Group, Webb P; Ovarian Cancer Patterns of Care Study Group.

Gynecol Oncol. 2013 May;129(2):310-7. doi: 10.1016/j.ygyno.2013.02.007. Epub 2013 Feb 9.

PMID:
23403164

Supplemental Content

Loading ...
Support Center